pre-market1 source ↓written by the desknot a recommendation
India Glycols has been downgraded to sell due to valuation and financial concerns. The company reported a PAT of ₹1,383.1 cr for the half-year, growing 25.6% YoY, with a ROCE of 11.4%. However, its Debt to EBITDA ratio of 3.21 raises leverage risks, overshadowing operational strengths.
Not investment advice. For informational purposes only.
OI Charts is not a SEBI-registered investment adviser or research analyst. This bulletin was written by the OI Charts desk from the public sources listed here. It is commentary on market conditions, not a basis for any investment decision and not a recommendation to buy or sell any security. Prices as of 3 Feb 2026, 07:13 IST.
Sourcesnews.google.com
The market after the news
Bulletin at 07:13 IST on 3 Feb 2026. Every change is measured from ₹864.50, the last close before it, on 2 Feb. Nifty 50 is measured over the same sessions.
| Session | Close ₹ | Change % | Nifty % |
|---|---|---|---|
| Before2 Feb | ₹864.50 | base | base |
| On the day3 Feb | ₹875.45 | ▲ +1.3% | ▲ +2.5%−1.3 pp difference |
| +1 session4 Feb | ₹905.00 | ▲ +4.7% | ▲ +2.7%+1.9 pp difference |
| +3 sessions6 Feb | ₹888.05 | ▲ +2.7% | ▲ +2.4%+0.3 pp difference |
| +5 sessions10 Feb | ₹990.65 | ▲ +14.6% | ▲ +3.4%+11.2 pp difference |
Source NSE UDiFF bhavcopy · INDIAGLYCO on the desk →